36m
Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds
Hims & Hers stock fell sharply on Monday after the FDA said it would take steps to restrict the sale of its compounded versions of popular weight-loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results